Ovarian cancer after menopause most commonly shows up as persistent abdominal bloating or swelling, feeling full quickly when eating, pelvic discomfort, and needing to urinate more often. The challenge is that these symptoms are vague and easy to dismiss, especially for postmenopausal women who may attribute them to aging or digestive changes. Nearly half of all ovarian cancer diagnoses occur in women between ages 55 and 74, making awareness of these symptoms particularly important after menopause.
The Most Common Symptoms
Ovarian cancer in its early stages often causes no noticeable symptoms at all. When symptoms do appear, they tend to mimic everyday complaints: bloating, constipation, back pain, fatigue. That overlap is exactly what makes ovarian cancer difficult to catch early. The core symptoms to watch for include:
- Abdominal bloating or swelling that doesn’t come and go
- Feeling full quickly or difficulty eating normal portions
- Pelvic or abdominal pain
- Urinary changes, especially needing to go more frequently or urgently
- Unexplained weight loss
- Persistent fatigue
- Changes in bowel habits, particularly new constipation
- Back pain
In a large UK study of women diagnosed with ovarian cancer, 65% had abdominal symptoms, 20% reported a change in bowel habits, and 13% had urinary symptoms. Loss of appetite and feeling full were also common and, notably, were associated with more advanced disease at diagnosis.
Bloating That Stays vs. Bloating That Passes
The word “bloating” gets used loosely, but research has identified a critical distinction. In a study comparing women with and without ovarian cancer, persistent abdominal distension, meaning your abdomen stays noticeably swollen day after day, was strongly linked to ovarian cancer, with an odds ratio of 5.2. Fluctuating bloating, the kind that comes and goes after meals or with your digestive cycle, showed no association with cancer at all.
About 86% of women later diagnosed with ovarian cancer experienced this persistent type of distension. In contrast, only about 5% of cancer cases involved the fluctuating kind. If your belly feels consistently larger or tighter over weeks, rather than swelling up after dinner and flattening out by morning, that pattern warrants a medical evaluation.
How These Symptoms Differ From Normal Aging
After menopause, many women experience occasional bloating, urinary changes, or fatigue as part of normal aging. The key differences with ovarian cancer symptoms are persistence and novelty. Menopausal changes typically stabilize over time. Ovarian cancer symptoms are new, don’t resolve on their own, and tend to worsen gradually. Nausea, shortness of breath, and difficulty eating a normal amount are particularly unusual for menopause alone.
A useful rule of thumb: if you’re experiencing any combination of bloating, pelvic pain, early fullness, or urinary urgency on most days for more than two to three weeks, and this is a change from your baseline, that pattern deserves investigation. No single symptom is a red flag on its own, but the combination and persistence matter.
Who Is Most at Risk
About 1.1% of women will be diagnosed with ovarian cancer during their lifetime. The disease is most frequently diagnosed in women between ages 55 and 64, and nearly 70% of cases occur in women over 55. That makes the postmenopausal years the highest-risk window.
Several factors can increase your individual risk. A family history of ovarian or breast cancer is one of the strongest, particularly if you carry certain inherited gene mutations. Women who have never been pregnant or who had their first pregnancy after age 35 also face somewhat higher odds. Endometriosis and obesity have been linked to increased risk as well.
Hormone replacement therapy has a complicated relationship with ovarian cancer risk. A large meta-analysis found that HRT use was associated with a modest increase in risk, roughly 13 to 20% depending on the study design. The risk appeared to climb further with use beyond 10 years. Both estrogen-only and combination estrogen-progesterone formulations carried similar levels of risk. However, more recent studies have shown weaker associations, suggesting the relationship may not be as strong as earlier data indicated. The type of ovarian cancer most associated with HRT use was serous ovarian cancer, the most common subtype.
How Ovarian Cancer Gets Diagnosed
There is no reliable screening test for ovarian cancer in the general population. Unlike cervical cancer (which has the Pap smear) or breast cancer (which has mammography), ovarian cancer lacks a proven screening tool. Diagnosis typically begins after symptoms prompt a visit to a doctor.
The initial workup usually involves a pelvic exam and a transvaginal ultrasound to look at the ovaries. In postmenopausal women, an ovary larger than 10 milliliters on ultrasound is considered suspicious, compared to a threshold of 20 milliliters in premenopausal women. If a complex mass is found, short-interval follow-up imaging is typically done within one to three months.
A blood test measuring a protein called CA-125 is also commonly used. In postmenopausal women without vaginal bleeding, a normal CA-125 level should be below 20 units per milliliter. For those with vaginal bleeding, the upper limit rises to 35. These thresholds are lower than in premenopausal women, where CA-125 naturally fluctuates with the menstrual cycle and can run as high as 50 in healthy individuals. Any elevation of CA-125 in a postmenopausal woman is considered a reason for referral to a specialist. It’s worth noting that CA-125 can be elevated by non-cancerous conditions too, so an abnormal result doesn’t automatically mean cancer.
Why Early Symptoms Get Missed
The biggest obstacle to early diagnosis is that ovarian cancer symptoms feel ordinary. Bloating, fatigue, and constipation are things most people experience regularly, and after menopause, it’s natural to assume new aches and digestive changes are just part of getting older. Many women and their doctors initially attribute these symptoms to irritable bowel syndrome, urinary tract issues, or stress.
Research consistently shows that women with ovarian cancer often had symptoms for months before diagnosis but didn’t recognize them as concerning. The symptoms tend to build slowly, making it hard to pinpoint when things shifted from normal to abnormal. Keeping a simple symptom log, even just noting which days you feel bloated, have pelvic pain, or skip meals because you feel full, can help you spot a persistent pattern that might otherwise blend into the background of daily life.